Evidence map›Paper›PMID 37576521›Full record

ArticleInfection and drug resistance2023

Antibacterial Activity of

Juanru Wei, Cong Zhang, Wei Ma, Juncheng Ma, Zhenzhen Liu, Fucai Ren, Ning Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. [Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
  3. Article
  4. Astragalin fromAntioxidants (Basel, Switzerland) · 2024
    Article
  5. Exploring Information Exchange betweenPlants (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juanru Wei *School of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Cong Zhang *School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, People's Republic of China.ORCID 0000-0002-5560-6013
Wei MaSchool of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Juncheng MaSchool of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Zhenzhen LiuSchool of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Fucai RenSchool of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Ning LiSchool of Pharmacy, Anhui Medical University, Hefei, 230032, People's Republic of China.
Anhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The drug resistance of Methods: Results: The ethanol extract coded as BRY, only inhibited Conclusion: BY2 has a broader antibacterial spectrum than BRY. Meanwhile, the inhibitory effect of BY2 on

Indexed as

antibacterialHaemophilus influenzaeplant extractStaphylococcus aureusStreptococcus pneumoniaeStreptococcus pyogenes

Identifiers

PMID37576521
PMCPMC10422991
OpenAlexW4385623695

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.